HEADER TRANSCRIPTION 22-DEC-06 2E5N TITLE SOLUTION STRUCTURE OF THE ELL_N2 DOMAIN OF TARGET OF RNA POLYMERASE II TITLE 2 ELONGATION FACTOR ELL2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA POLYMERASE II ELONGATION FACTOR ELL2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ELL_N2 DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELL2; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P060508-09; SOURCE 8 OTHER_DETAILS: CELL FREE PROTEIN SYNTHESIS KEYWDS ELL_N2 DOMAIN, RNA POLYMERASE II ELONGATION FACTOR ELL2, STRUCTURAL KEYWDS 2 GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND KEYWDS 3 FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 4 INITIATIVE, RSGI, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR W.DANG,Y.MUTO,M.INOUE,T.KIGAWA,M.SHIROUZU,T.TERADA,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2E5N 1 REMARK SEQADV REVDAT 2 24-FEB-09 2E5N 1 VERSN REVDAT 1 26-JUN-07 2E5N 0 JRNL AUTH W.DANG,Y.MUTO,M.INOUE,T.KIGAWA,M.SHIROUZU,T.TERADA, JRNL AUTH 2 S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE ELL_N2 DOMAIN OF TARGET OF RNA JRNL TITL 2 POLYMERASE II ELONGATION FACTOR ELL2 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 2.6, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT,P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2E5N COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000026255. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 20MM D-TRIS-HCL(PH 7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 90% REMARK 210 H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20031121, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9814, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, STRUCTURES REMARK 210 WITH THE LOWEST ENERGY, TARGET REMARK 210 FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 69 178.58 -48.76 REMARK 500 1 LEU A 76 178.74 -54.39 REMARK 500 1 SER A 93 -70.39 -70.27 REMARK 500 1 LEU A 99 94.45 -68.37 REMARK 500 2 ARG A 15 -72.94 -33.19 REMARK 500 2 ALA A 34 -36.74 -35.81 REMARK 500 2 GLN A 37 -36.64 -38.85 REMARK 500 2 LYS A 69 -177.50 -51.71 REMARK 500 2 ILE A 86 -64.37 -96.60 REMARK 500 2 GLU A 92 -19.79 -48.99 REMARK 500 2 LEU A 99 93.15 -65.64 REMARK 500 3 SER A 3 151.38 -42.67 REMARK 500 3 ALA A 23 -74.63 -46.61 REMARK 500 3 ALA A 34 -38.70 -33.65 REMARK 500 3 SER A 61 -30.76 -39.62 REMARK 500 3 LYS A 69 -179.33 -49.57 REMARK 500 3 LEU A 76 167.90 -45.24 REMARK 500 3 ASP A 79 30.73 -98.16 REMARK 500 3 ILE A 86 -62.78 -92.64 REMARK 500 4 ALA A 34 -32.50 -35.57 REMARK 500 4 SER A 61 -33.12 -38.51 REMARK 500 4 LYS A 69 -175.85 -51.14 REMARK 500 4 LEU A 76 175.75 -52.96 REMARK 500 4 PRO A 81 2.54 -69.77 REMARK 500 5 ALA A 34 -37.00 -34.82 REMARK 500 5 GLN A 37 -35.92 -38.27 REMARK 500 5 LYS A 69 -178.30 -51.72 REMARK 500 5 VAL A 72 -31.36 -39.98 REMARK 500 5 LEU A 76 169.89 -46.54 REMARK 500 5 ILE A 86 -61.90 -96.56 REMARK 500 5 LEU A 99 96.65 -58.69 REMARK 500 6 SER A 2 56.48 -96.32 REMARK 500 6 ALA A 34 -35.74 -34.13 REMARK 500 6 SER A 61 -32.67 -34.70 REMARK 500 6 LYS A 69 179.16 -50.08 REMARK 500 6 ASP A 70 -60.56 -91.27 REMARK 500 6 LEU A 76 166.54 -42.86 REMARK 500 6 PRO A 81 3.40 -69.79 REMARK 500 6 LYS A 98 -71.90 -69.30 REMARK 500 6 LEU A 99 94.53 -56.68 REMARK 500 7 SER A 6 108.71 -50.76 REMARK 500 7 ALA A 34 -29.92 -37.37 REMARK 500 7 LYS A 69 -176.13 -51.29 REMARK 500 7 LEU A 76 163.43 -44.46 REMARK 500 7 ILE A 86 -64.26 -94.88 REMARK 500 7 LYS A 98 -60.94 -93.23 REMARK 500 7 LEU A 99 93.75 -69.21 REMARK 500 8 SER A 5 -74.53 -83.94 REMARK 500 8 LYS A 69 -179.37 -49.70 REMARK 500 8 LEU A 76 171.97 -47.17 REMARK 500 REMARK 500 THIS ENTRY HAS 135 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSI002011950.1 RELATED DB: TARGETDB DBREF 2E5N A 8 100 UNP O00472 ELL2_HUMAN 200 292 SEQADV 2E5N GLY A 1 UNP O00472 CLONING ARTIFACT SEQADV 2E5N SER A 2 UNP O00472 CLONING ARTIFACT SEQADV 2E5N SER A 3 UNP O00472 CLONING ARTIFACT SEQADV 2E5N GLY A 4 UNP O00472 CLONING ARTIFACT SEQADV 2E5N SER A 5 UNP O00472 CLONING ARTIFACT SEQADV 2E5N SER A 6 UNP O00472 CLONING ARTIFACT SEQADV 2E5N GLY A 7 UNP O00472 CLONING ARTIFACT SEQRES 1 A 100 GLY SER SER GLY SER SER GLY THR ILE SER GLN ARG PRO SEQRES 2 A 100 TYR ARG ASP ARG VAL ILE HIS LEU LEU ALA LEU LYS ALA SEQRES 3 A 100 TYR LYS LYS PRO GLU LEU LEU ALA ARG LEU GLN LYS ASP SEQRES 4 A 100 GLY VAL ASN GLN LYS ASP LYS ASN SER LEU GLY ALA ILE SEQRES 5 A 100 LEU GLN GLN VAL ALA ASN LEU ASN SER LYS ASP LEU SER SEQRES 6 A 100 TYR THR LEU LYS ASP TYR VAL PHE LYS GLU LEU GLN ARG SEQRES 7 A 100 ASP TRP PRO GLY TYR SER GLU ILE ASP ARG ARG SER LEU SEQRES 8 A 100 GLU SER VAL LEU SER ARG LYS LEU ASN HELIX 1 1 TYR A 14 LEU A 24 1 11 HELIX 2 2 LYS A 29 ASP A 39 1 11 HELIX 3 3 GLN A 43 VAL A 56 1 14 HELIX 4 4 VAL A 72 GLU A 75 1 4 HELIX 5 5 ASP A 87 LYS A 98 1 12 SHEET 1 A 2 ALA A 57 ASN A 60 0 SHEET 2 A 2 SER A 65 LEU A 68 -1 O THR A 67 N ASN A 58 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1